Neurology News

DENVER — In patients with ischemic stroke, treatment with endovascular therapy with medical care led to better functional outcomes at 1 year compared with medical care alone. according to a speaker.

DENVER — Deterioration of memory and executive functions were associated with worsening quality of life for those with Parkinson’s disease over a 3-year period, according to a poster at the American Academy of Neurology annual meeting.

BOSTON — There is some evidence that cannabinoids may help with neuropathic pain, chemotherapy-induced nausea/vomiting and MS-associated spasticity, “but it’s not exactly a slam dunk,” a speaker said.

DENVER — Exposure to airborne manganese may be a significant contributing factor to risk of Parkinson’s disease, according to a poster from the American Academy of Neurology annual meeting.

Nearly all study participants believed to have a synucleinopathy had the presence of alpha-synuclein in their skin samples, according to a study presented at the American Academy of Neurology annual meeting.

When it comes to work-life balance, providers in the past skewed more toward work than life.

Dana-Farber Cancer Institute launched a neuro-inclusive oncology care and empowerment program designed to support adults with intellectual and/or developmental disabilities on their cancer journeys.

The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with Fragile X syndrome, according to the manufacturer.

DENVER — While rare and associated with a limited differential diagnosis, abrupt-onset dementia may be treatable with prompt recognition and early intervention, according to a poster at the American Academy of Neurology annual meeting.

BOSTON — “We should be embracing [AI] and trying to make this a priority to get this right, because I don’t know any alternative to get us out of this frustration right now outside of this technology,” Eric Topol, MD, said.